{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T08:36:29Z","timestamp":1768293389825,"version":"3.49.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T00:00:00Z","timestamp":1410825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s10096-014-2240-6","type":"journal-article","created":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T19:07:57Z","timestamp":1414696077000},"page":"367-383","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study"],"prefix":"10.1007","volume":"34","author":[{"given":"B.","family":"Minea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Nastasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. F.","family":"Moraru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kolecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. M.","family":"Flonta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Marincu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Man","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Toma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lupse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Doroftei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Marangoci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pinteala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Boekhout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,16]]},"reference":[{"key":"2240_CR1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jinf.2010.06.018","volume":"61","author":"T Lehrnbecher","year":"2010","unstructured":"Lehrnbecher T, Frank C, Engels K, Kriener S, Groll AH, Schwabe D (2010) Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 61:259\u2013265. doi: 10.1016\/j.jinf.2010.06.018","journal-title":"J Infect"},{"issue":"Pt 7","key":"2240_CR2","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1099\/jmm.0.46548-0","volume":"55","author":"DA Enoch","year":"2006","unstructured":"Enoch DA, Ludlam HA, Brown NM (2006) Invasive fungal infections: a review of epidemiology and management options. J Med Microbiol 55(Pt 7):809\u2013818. doi: 10.1099\/jmm.0.46548-0","journal-title":"J Med Microbiol"},{"issue":"8","key":"2240_CR3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/jama.1995.03530080055041","volume":"274","author":"JL Vincent","year":"1995","unstructured":"Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH et al (1995) The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274(8):639\u2013644","journal-title":"JAMA"},{"key":"2240_CR4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/2110-5820-1-37","volume":"1","author":"P Eggimann","year":"2011","unstructured":"Eggimann P, Bille J, Marchetti O (2011) Diagnosis of invasive candidiasis in the ICU. Ann Intensive Care 1:37. doi: 10.1186\/2110-5820-1-37","journal-title":"Ann Intensive Care"},{"issue":"9","key":"2240_CR5","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1086\/378745","volume":"37","author":"O Gudlaugsson","year":"2003","unstructured":"Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S et al (2003) Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 37(9):1172\u20131177. doi: 10.1086\/378745","journal-title":"Clin Infect Dis"},{"key":"2240_CR6","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00520-011-1154-4","volume":"19","author":"R-J Bensadoun","year":"2011","unstructured":"Bensadoun R-J, Patton LL, Lalla RV, Epstein JB (2011) Oropharyngeal candidiasis in head and neck cancer patients treated with radiation: update 2011. Support Care Cancer 19:737\u2013744. doi: 10.1007\/s00520-011-1154-4","journal-title":"Support Care Cancer"},{"key":"2240_CR7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.archoralbio.2010.11.018","volume":"56","author":"RM Bremenkamp","year":"2011","unstructured":"Bremenkamp RM, Caris AR, Jorge AOC, Back-Brito GN, Mota AJ, Balducci I et al (2011) Prevalence and antifungal resistance profile of Candida spp. oral isolates from patients with type 1 and 2 diabetes mellitus. Arch Oral Biol 56:549\u2013555","journal-title":"Arch Oral Biol"},{"key":"2240_CR8","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.mpmed.2010.02.001","volume":"38","author":"JD Sobel","year":"2010","unstructured":"Sobel JD (2010) Genital candidiasis. Medicine (Baltimore) 38:286\u2013290. doi: 10.1016\/j.mpmed.2010.02.001","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"2240_CR9","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/JCM.00409-07","volume":"45","author":"MA Pfaller","year":"2007","unstructured":"Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Meis JF, Gould IM et al (2007) Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol 45(6):735\u2013745. doi: 10.1128\/JCM.00409-07","journal-title":"J Clin Microbiol"},{"key":"2240_CR10","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1111\/j.1439-0507.2011.02165.x","volume":"55","author":"AF Schmalreck","year":"2012","unstructured":"Schmalreck AF, Willinger B, Haase G, Blum G, Lass-Fl\u00f6rl C, Fegeler W et al (2012) Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study. Mycoses 55:e124\u2013e137. doi: 10.1111\/j.1439-0507.2011.02165.x","journal-title":"Mycoses"},{"issue":"1","key":"2240_CR11","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1128\/AAC.01543-08","volume":"53","author":"M Cuenca-Estrella","year":"2009","unstructured":"Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Monzon A, Buitrago MJ, Rodriguez-Tudela JL (2009) Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds. Antimicrob Agents Chemother 53(1):2192\u20132195. doi: 10.1128\/AAC.01543-08","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"2240_CR12","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1128\/JCM.02117-09","volume":"48","author":"MA Pfaller","year":"2010","unstructured":"Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D, Tullio V et al (2010) Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol 48(4):1366\u20131377. doi: 10.1128\/JCM.02117-09","journal-title":"J Clin Microbiol"},{"key":"2240_CR13","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.diagmicrobio.2013.03.003","volume":"76","author":"Y-L Yang","year":"2013","unstructured":"Yang Y-L, Chen H-T, Lin C-C, Chu W-L, Lo H-J; TSARY Hospitals (2013) Species distribution and drug susceptibilities of Candida isolates in TSARY 2010. Diagn Microbiol Infect Dis 76:182\u2013186. doi: 10.1016\/j.diagmicrobio.2013.03.003","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"2240_CR14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/2047-783X-16-4-187","volume":"16","author":"AC Rodloff","year":"2011","unstructured":"Rodloff AC, Koch D, Schaumann R (2011) Epidemiology and antifungal resistance in invasive candidiasis. Eur J Med Res 16(4):187\u2013195. doi: 10.1186\/2047-783X-16-4-187","journal-title":"Eur J Med Res"},{"issue":"1","key":"2240_CR15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12281-012-0125-7","volume":"7","author":"A Espinel-Ingroff","year":"2013","unstructured":"Espinel-Ingroff A, Cuenca-Estrella M, Cant\u00f3n E (2013) EUCAST and CLSI: working together towards a harmonized method for antifungal susceptibility testing. Curr Fungal Infect Rep 7(1):59\u201367. doi: 10.1007\/s12281-012-0125-7","journal-title":"Curr Fungal Infect Rep"},{"key":"2240_CR16","doi-asserted-by":"crossref","unstructured":"Cisterna R, Teller\u00eda O, Hernaez S, Ezpeleta G (2012) Impact of the new clinical breaking points proposed by the Clinical and Laboratory Standards Institute (CLSI) in the antifungal susceptibility profile of clinical strains isolated from invasive bloodstream Candida spp. Infections in Spain. Clin Med Insights Ther 4:19\u201327. doi: 10.4137\/CMT.S8293","DOI":"10.4137\/CMT.S8293"},{"key":"2240_CR17","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved Standard\u2014Third Edition. CLSI document M27-A3"},{"issue":"11","key":"2240_CR18","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1128\/JCM.01283-12","volume":"50","author":"SR Lockhart","year":"2012","unstructured":"Lockhart SR, Iqbal N, Cleveland AA, Farley MM, Harrison LH, Bolden CB et al (2012) Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011. J Clin Microbiol 50(11):3435\u20133442. doi: 10.1128\/JCM.01283-12","journal-title":"J Clin Microbiol"},{"key":"2240_CR19","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2004) Method for antifungal disk diffusion susceptibility testing of yeasts; Approved Guideline. CLSI document M44-A"},{"key":"2240_CR20","unstructured":"Normenausschuss Medizin (NAMed) im DIN Deutsches Institut f\u00fcr Normung e.V. (2002) DIN 58940-84:2002-10. Medical microbiology \u2013 susceptibility testing of microbial pathogens to antimicrobial agents \u2013 part 84: microdilution; special requirements for testing of fungi against antifungal agents"},{"key":"2240_CR21","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1469-0691.2007.01935.x","volume":"14","author":"Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST)","year":"2008","unstructured":"Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST) (2008) EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin Microbiol Infect 14:398\u2013405. doi: 10.1111\/j.1469-0691.2007.01935.x","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"2240_CR22","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1128\/JCM.05474-11","volume":"49","author":"J Pem\u00e1n","year":"2011","unstructured":"Pem\u00e1n J, Cant\u00f3n E, Linares-Sicilia MJ, Rosell\u00f3 EM, Borrell N, Ruiz-P\u00e9rez-de-Pipaon MT et al (2011) Epidemiology and antifungal susceptibility of bloodstream fungal isolates in pediatric patients: a Spanish multicenter prospective survey. J Clin Microbiol 49(12):4158\u20134163. doi: 10.1128\/JCM.05474-11","journal-title":"J Clin Microbiol"},{"key":"2240_CR23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11046-011-9455-1","volume":"172","author":"M Mare\u015f","year":"2011","unstructured":"Mare\u015f M, N\u0103stas\u0103 V, Ramona FM, Doroftei B, Stefanache A (2011) Comparative in vitro activities of fluconazole, voriconazole, and MXP-4509 against Romanian blood yeast isolates. Mycopathologia 172:487\u2013492. doi: 10.1007\/s11046-011-9455-1","journal-title":"Mycopathologia"},{"key":"2240_CR24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.rinphs.2011.07.001","volume":"1","author":"N Marangoci","year":"2011","unstructured":"Marangoci N, Mares M, Silion M, Fifere A, Varganici C, Nicolescu A et al (2011) Inclusion complex of a new propiconazole derivative with \u03b2-cyclodextrin: NMR, ESI-MS and preliminary pharmacological studies. Results Pharma Sci 1:27\u201337. doi: 10.1016\/j.rinphs.2011.07.001","journal-title":"Results Pharma Sci"},{"key":"2240_CR25","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.3762\/bjoc.8.247","volume":"8","author":"A Fifere","year":"2012","unstructured":"Fifere A, Marangoci N, Maier S, Coroaba A, Maftei D, Pinteala M (2012) Theoretical study on \u03b2-cyclodextrin inclusion complexes with propiconazole and protonated propiconazole. Beilstein J Org Chem 8:2191\u20132201. doi: 10.3762\/bjoc.8.247","journal-title":"Beilstein J Org Chem"},{"key":"2240_CR26","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1439-0507.2010.01939.x","volume":"54","author":"O Romeo","year":"2011","unstructured":"Romeo O, Criseo G (2011) Candida africana and its closest relatives. Mycoses 54:475\u2013486. doi: 10.1111\/j.1439-0507.2010.01939.x","journal-title":"Mycoses"},{"key":"2240_CR27","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1128\/JCM.00470-13","volume":"51","author":"A Kolecka","year":"2013","unstructured":"Kolecka A, Khayhan K, Groenewald M, Theelen B, Arabatzis M, Velegraki A et al (2013) Identification of medically relevant species of arthroconidial yeasts by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 51:2491\u20132500. doi: 10.1128\/JCM.00470-13","journal-title":"J Clin Microbiol"},{"issue":"11","key":"2240_CR28","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1128\/JCM.02248-12","volume":"50","author":"E Cendejas-Bueno","year":"2012","unstructured":"Cendejas-Bueno E, Kolecka A, Alastruey-Izquierdo A, Theelen B, Groenewald M, Kostrzewa M et al (2012) Reclassification of the Candida haemulonii complex as Candida haemulonii (C. haemulonii group I), C. duobushaemulonii sp. nov. (C. haemulonii group II), and C. haemulonii var. vulnera var. nov.: three multiresistant human pathogenic yeasts. J Clin Microbiol 50(11):3641\u20133651. doi: 10.1128\/JCM.02248-12","journal-title":"J Clin Microbiol"},{"key":"2240_CR29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/B978-0-12-372180-8.50042-1","volume-title":"PCR protocols: a guide to methods and applications","author":"TJ White","year":"1990","unstructured":"White TJ, Bruns TD, Lee SB, Taylor JW (1990) Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ (ed) PCR protocols: a guide to methods and applications. Academic Press, New York, pp 315\u2013322"},{"issue":"8","key":"2240_CR30","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1128\/jb.172.8.4238-4246.1990","volume":"172","author":"R Vilgalys","year":"1990","unstructured":"Vilgalys R, Hester M (1990) Rapid genetic identification and mapping of enzymatically amplified ribosomal DNA from several Cryptococcus species. J Bacteriol 172(8):4238\u20134246","journal-title":"J Bacteriol"},{"key":"2240_CR31","doi-asserted-by":"crossref","first-page":"E246","DOI":"10.1111\/j.1469-0691.2012.03880.x","volume":"18","author":"MC Arendrup","year":"2012","unstructured":"Arendrup MC, Cuenca-Estrella M, Lass-Fl\u00f6rl C, Hope W; EUCAST-AFST (2012) EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST). Clin Microbiol Infect 18:E246\u2013E247","journal-title":"Clin Microbiol Infect"},{"key":"2240_CR32","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2013) Antifungal agents. Breakpoint tables for interpretation of MICs. Version 6.1, valid from 2013-03-11. Available online at: http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/AFST\/Antifungal_breakpoints_v_6.1.pdf"},{"key":"2240_CR33","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1469-0691.2008.02087.x","volume":"14","author":"Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing","year":"2008","unstructured":"Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing (2008) EUCAST Technical Note on voriconazole. Clin Microbiol Infect 14:985\u2013987. doi: 10.1111\/j.1469-0691.2008.02087.x","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"2240_CR34","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/AAC.01140-07","volume":"52","author":"E Dannaoui","year":"2008","unstructured":"Dannaoui E, Lortholary O, Raoux D, Bougnoux ME, Galeazzi G, Lawrence C et al (2008) Comparative in vitro activities of caspofungin and micafungin, determined using the method of the European Committee on Antimicrobial Susceptibility Testing, against yeast isolates obtained in France in 2005\u20132006. Antimicrob Agents Chemother 52(2):778\u2013781. doi: 10.1128\/AAC.01140-07","journal-title":"Antimicrob Agents Chemother"},{"key":"2240_CR35","volume-title":"The yeasts, a taxonomic study","year":"2011","unstructured":"Kurtzman CP, Fell JW, Boekhout T (eds) (2011) The yeasts, a taxonomic study, 5th edn. Elsevier, Amsterdam, Oxford","edition":"5"},{"key":"2240_CR36","doi-asserted-by":"crossref","first-page":"560406","DOI":"10.1155\/2013\/560406","volume":"2013","author":"S Ahmad","year":"2013","unstructured":"Ahmad S, Khan ZU, Johny M, Ashour NM, Al-Tourah WH, Joseph L et al (2013) Isolation of Lodderomyces elongisporus from the catheter tip of a fungemia patient in the Middle East. Case Rep Med 2013:560406. doi: 10.1155\/2013\/560406","journal-title":"Case Rep Med"},{"issue":"9","key":"2240_CR37","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1128\/JCM.40.9.3135-3139.2002","volume":"40","author":"M Martinez","year":"2002","unstructured":"Martinez M, L\u00f3pez-Ribot JL, Kirkpatrick WR, Coco BJ, Bachmann SP, Patterson TF (2002) Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole. J Clin Microbiol 40(9):3135\u20133139. doi: 10.1128\/JCM.40.9.3135-3139.2002","journal-title":"J Clin Microbiol"},{"issue":"3","key":"2240_CR38","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1128\/AAC.41.3.617","volume":"41","author":"GP Moran","year":"1997","unstructured":"Moran GP, Sullivan DJ, Henman MC, McCreary CE, Harrington BJ, Shanley DB et al (1997) Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob Agents Chemother 41(3):617\u2013623","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 3","key":"2240_CR39","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/1469-0691.12360","volume":"20","author":"MC Arendrup","year":"2014","unstructured":"Arendrup MC, Boekhout T, Akova M, Meis JF, Cornely OA, Lortholary O et al (2014) ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections. Clin Microbiol Infect 20(Suppl 3):76\u201398. doi: 10.1111\/1469-0691.12360","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"2240_CR40","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12281-010-0005-y","volume":"4","author":"JA Vazquez","year":"2010","unstructured":"Vazquez JA (2010) Trichosporon infection. Curr Fungal Infect Rep 4(1):52\u201358. doi: 10.1007\/s12281-010-0005-y","journal-title":"Curr Fungal Infect Rep"},{"issue":"1","key":"2240_CR41","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1128\/JCM.43.1.476-478.2005","volume":"43","author":"DJ Diekema","year":"2005","unstructured":"Diekema DJ, Petroelje B, Messer SA, Hollis RJ, Pfaller MA (2005) Activities of available and investigational antifungal agents against Rhodotorula species. J Clin Microbiol 43(1):476\u2013478. doi: 10.1128\/JCM.43.1.476-478.2005","journal-title":"J Clin Microbiol"},{"key":"2240_CR42","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11908-006-0016-6","volume":"8","author":"JD Sobel","year":"2006","unstructured":"Sobel JD (2006) The emergence of non-albicans Candida species as causes of invasive candidiasis and candidemia. Curr Infect Dis Rep 8:427\u2013433","journal-title":"Curr Infect Dis Rep"},{"key":"2240_CR43","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1439-0507.2009.01691.x","volume":"52","author":"C Lass-Fl\u00f6rl","year":"2009","unstructured":"Lass-Fl\u00f6rl C (2009) The changing face of epidemiology of invasive fungal disease in Europe. Mycoses 52:197\u2013205. doi: 10.1111\/j.1439-0507.2009.01691.x","journal-title":"Mycoses"},{"key":"2240_CR44","doi-asserted-by":"crossref","first-page":"e954","DOI":"10.1016\/j.ijid.2010.04.006","volume":"14","author":"ME Falagas","year":"2010","unstructured":"Falagas ME, Roussos N, Vardakas KZ (2010) Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review. Int J Infect Dis 14:e954\u2013e966. doi: 10.1016\/j.ijid.2010.04.006","journal-title":"Int J Infect Dis"},{"key":"2240_CR45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1773-035X(13)71944-0","volume":"2013","author":"D Toubas","year":"2013","unstructured":"Toubas D (2013) Epid\u00e9miologie des candidoses invasives\/Epidemiology of invasive candidiasis. Rev Francoph Lab 2013:27\u201336. doi: 10.1016\/S1773-035X(13)71944-0","journal-title":"Rev Francoph Lab"},{"issue":"1","key":"2240_CR46","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/JCM.01811-10","volume":"49","author":"MC Arendrup","year":"2011","unstructured":"Arendrup MC, Bruun B, Christensen JJ, Fuursted K, Johansen HK, Kj\u00e6ldgaard P et al (2011) National surveillance of fungemia in Denmark (2004 to 2009). J Clin Microbiol 49(1):325\u2013334. doi: 10.1128\/JCM.01811-10","journal-title":"J Clin Microbiol"},{"key":"2240_CR47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12281-011-0081-7","volume":"6","author":"J Sifuentes-Osornio","year":"2012","unstructured":"Sifuentes-Osornio J, Corzo-Le\u00f3n DE, Ponce-de-Le\u00f3n LA (2012) Epidemiology of invasive fungal infections in Latin America. Curr Fungal Infect Rep 6:23\u201334. doi: 10.1007\/s12281-011-0081-7","journal-title":"Curr Fungal Infect Rep"},{"issue":"5","key":"2240_CR48","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1086\/513615","volume":"28","author":"AL Colombo","year":"2007","unstructured":"Colombo AL, Guimar\u00e3es T, Silva LR, de Almeida Monfardini LP, Cunha AK, Rady P et al (2007) Prospective observational study of candidemia in S\u00e3o Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality. Infect Control Hosp Epidemiol 28(5):570\u2013576. doi: 10.1086\/513615","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2240_CR49","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s15010-013-0432-0","volume":"41","author":"MT Montagna","year":"2013","unstructured":"Montagna MT, Caggiano G, Lovero G, De Giglio O, Coretti C, Cuna T et al (2013) Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project). Infection 41:645\u2013653. doi: 10.1007\/s15010-013-0432-0","journal-title":"Infection"},{"key":"2240_CR50","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s15010-013-0570-4","volume":"42","author":"SJ Taj-Aldeen","year":"2014","unstructured":"Taj-Aldeen SJ, Kolecka A, Boesten R, Alolaqi A, Almaslamani M, Chandra P et al (2014) Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and susceptibility pattern. Infection 42:393\u2013404. doi: 10.1007\/s15010-013-0570-4","journal-title":"Infection"},{"key":"2240_CR51","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ijantimicag.2006.01.002","volume":"27","author":"AM Tortorano","year":"2006","unstructured":"Tortorano AM, Kibbler C, Peman J, Bernhardt H, Klingspor L, Grillot R (2006) Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents 27:359\u2013366. doi: 10.1016\/j.ijantimicag.2006.01.002","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"2240_CR52","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/jac\/dki473","volume":"57","author":"C Charlier","year":"2006","unstructured":"Charlier C, Hart E, Lefort A, Ribaud P, Dromer F, Denning DW et al (2006) Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? J Antimicrob Chemother 57(3):384\u2013410. doi: 10.1093\/jac\/dki473","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"2240_CR53","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","volume":"56","author":"BD Alexander","year":"2013","unstructured":"Alexander BD, Johnson MD, Pfeiffer CD, Jim\u00e9nez-Ortigosa C, Catania J, Booker R et al (2013) Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis 56(12):1724\u20131732. doi: 10.1093\/cid\/cit136","journal-title":"Clin Infect Dis"},{"issue":"7","key":"2240_CR54","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1128\/AAC.00262-08","volume":"52","author":"G Garcia-Effron","year":"2008","unstructured":"Garcia-Effron G, Katiyar SK, Park S, Edlind TD, Perlin DS (2008) A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility. Antimicrob Agents Chemother 52(7):2305\u20132312. doi: 10.1128\/AAC.00262-08","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"2240_CR55","doi-asserted-by":"crossref","first-page":"e24198","DOI":"10.1371\/journal.pone.0024198","volume":"6","author":"M Bassetti","year":"2011","unstructured":"Bassetti M, Taramasso L, Nicco E, Molinari MP, Mussap M, Viscoli C (2011) Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS One 6(9):e24198. doi: 10.1371\/journal.pone.0024198","journal-title":"PLoS One"},{"key":"2240_CR56","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jinf.2011.11.002","volume":"64","author":"MN Chitasombat","year":"2012","unstructured":"Chitasombat MN, Kofteridis DP, Jiang Y, Tarrand J, Lewis RE, Kontoyiannis DP (2012) Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer. J Infect 64:68\u201375. doi: 10.1016\/j.jinf.2011.11.002","journal-title":"J Infect"},{"issue":"43","key":"2240_CR57","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1086\/507036","volume":"15","author":"LW Lunardi","year":"2006","unstructured":"Lunardi LW, Aquino VR, Zimerman RA, Goldani LZ (2006) Epidemiology and outcome of Rhodotorula fungemia in a tertiary care hospital. Clin Infect Dis 15(43):e60\u2013e63. doi: 10.1086\/507036","journal-title":"Clin Infect Dis"},{"key":"2240_CR58","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jmwh.2006.07.005","volume":"51","author":"J Mashburn","year":"2006","unstructured":"Mashburn J (2006) Etiology, diagnosis, and management of vaginitis. J Midwifery Womens Health 51:423\u2013430. doi: 10.1016\/j.jmwh.2006.07.005","journal-title":"J Midwifery Womens Health"},{"key":"2240_CR59","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0140-6736(07)60917-9","volume":"369","author":"JD Sobel","year":"2007","unstructured":"Sobel JD (2007) Vulvovaginal candidosis. Lancet 369:1961\u20131971. doi: 10.1016\/S0140-6736(07)60917-9","journal-title":"Lancet"},{"key":"2240_CR60","first-page":"96","volume":"70","author":"F Katiraee","year":"2012","unstructured":"Katiraee F, Khosravi AR, Khalaj V, Hajiabdolbaghi M, Khaksar AA, Rasoulinejad M (2012) In vitro antifungal susceptibility of oral Candida species from Iranian HIV infected patients. Tehran Univ Med J 70:96\u2013103","journal-title":"Tehran Univ Med J"},{"key":"2240_CR61","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.tripleo.2009.11.026","volume":"109","author":"GR Thompson 3rd","year":"2010","unstructured":"Thompson GR 3rd, Patel PK, Kirkpatrick WR, Westbrook SD, Berg D, Erlandsen J et al (2010) Oropharyngeal candidiasis in the era of antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109:488\u2013495. doi: 10.1016\/j.tripleo.2009.11.026","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"2240_CR62","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejogrb.2008.12.020","volume":"144","author":"A Ahmad","year":"2009","unstructured":"Ahmad A, Khan AU (2009) Prevalence of Candida species and potential risk factors for vulvovaginal candidiasis in Aligarh, India. Eur J Obstet Gynecol Reprod Biol 144:68\u201371. doi: 10.1016\/j.ejogrb.2008.12.020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2240_CR63","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jiph.2012.12.007","volume":"6","author":"S Al Mubarak","year":"2013","unstructured":"Al Mubarak S, Robert AA, Baskaradoss JK, Al-Zoman K, Al Sohail A, Alsuwyed A et al (2013) The prevalence of oral Candida infections in periodontitis patients with type 2 diabetes mellitus. J Infect Public Health 6:296\u2013301. doi: 10.1016\/j.jiph.2012.12.007","journal-title":"J Infect Public Health"},{"key":"2240_CR64","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mycmed.2009.11.003","volume":"20","author":"F Katiraee","year":"2010","unstructured":"Katiraee F, Khosravi AR, Khalaj V, Hajiabdolbaghi M, Khaksar A, Rasoolinejad M et al (2010) Oropharyngeal candidiasis and oral yeast colonization in Iranian human immunodeficiency virus positive patients. J Mycol M\u00e9dicale J Med Mycol 20:8\u201314. doi: 10.1016\/j.mycmed.2009.11.003","journal-title":"J Mycol M\u00e9dicale J Med Mycol"},{"key":"2240_CR65","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s12094-012-0861-8","volume":"14","author":"A Ma\u00f1as","year":"2012","unstructured":"Ma\u00f1as A, Cerezo L, de la Torre A, Garc\u00eda M, Alburquerque H, Lude\u00f1a B et al (2012) Epidemiology and prevalence of oropharyngeal candidiasis in Spanish patients with head and neck tumors undergoing radiotherapy treatment alone or in combination with chemotherapy. Clin Transl Oncol 14:740\u2013746. doi: 10.1007\/s12094-012-0861-8","journal-title":"Clin Transl Oncol"},{"key":"2240_CR66","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0301-2115(03)00096-4","volume":"110","author":"S Corsello","year":"2003","unstructured":"Corsello S, Spinillo A, Osnengo G, Penna C, Guaschino S, Beltrame A et al (2003) An epidemiological survey of vulvovaginal candidiasis in Italy. Eur J Obstet Gynecol Reprod Biol 110:66\u201372. doi: 10.1016\/S0301-2115(03)00096-4","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2240_CR67","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.gyobfe.2011.08.001","volume":"40","author":"J-M Bohbot","year":"2012","unstructured":"Bohbot J-M, Sednaoui P, Verriere F, Achhammer I (2012) Diversit\u00e9 \u00e9tiologique des vaginites. Gyn\u00e9col Obst\u00e9t Fertil 40:578\u2013581. doi: 10.1016\/j.gyobfe.2011.08.001","journal-title":"Gyn\u00e9col Obst\u00e9t Fertil"},{"issue":"1","key":"2240_CR68","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejogrb.2005.09.015","volume":"126","author":"O Grigoriou","year":"2006","unstructured":"Grigoriou O, Baka S, Makrakis E, Hassiakos D, Kapparos G, Kouskouni E (2006) Prevalence of clinical vaginal candidiasis in a university hospital and possible risk factors. Eur J Obstet Gynecol Reprod Biol 126(1):121\u2013125. doi: 10.1016\/j.ejogrb.2005.09.015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2240_CR69","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1023\/B:MYCO.0000020594.35357.b0","volume":"157","author":"M Sojakova","year":"2004","unstructured":"Sojakova M, Liptajova D, Borovsky M, Subik J (2004) Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia. Mycopathologia 157:163\u2013169","journal-title":"Mycopathologia"},{"key":"2240_CR70","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.mycmed.2012.08.002","volume":"22","author":"L Bulacio","year":"2012","unstructured":"Bulacio L, Paz M, Ramad\u00e1n S, Ramos L, Pairoba C, Sortino M et al (2012) Oral infections caused by yeasts in patients with head and neck cancer undergoing radiotherapy. Identification of the yeasts and evaluation of their antifungal susceptibility. J Mycol M\u00e9dicale 22:348\u2013353. doi: 10.1016\/j.mycmed.2012.08.002","journal-title":"J Mycol M\u00e9dicale"},{"key":"2240_CR71","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1348-8643(13)00006-2","volume":"10","author":"Y Kamikawa","year":"2013","unstructured":"Kamikawa Y, Nagayama T, Fujisaki J, Hirabayashi D, Kawasaki K, Hamada T et al (2013) Clinical study on anti-fungal drug activity against clinically isolated strains of oral Candida species. Oral Sci Int 10:87\u201394. doi: 10.1016\/S1348-8643(13)00006-2","journal-title":"Oral Sci Int"},{"key":"2240_CR72","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1471-2334-13-82","volume":"13","author":"A Mulu","year":"2013","unstructured":"Mulu A, Kassu A, Anagaw B, Moges B, Gelaw A, Alemayehu M et al (2013) Frequent detection of \u2018azole\u2019 resistant Candida species among late presenting AIDS patients in northwest Ethiopia. BMC Infect Dis 13:82. doi: 10.1186\/1471-2334-13-82","journal-title":"BMC Infect Dis"},{"key":"2240_CR73","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.tripleo.2004.05.017","volume":"98","author":"CA Migliorati","year":"2004","unstructured":"Migliorati CA, Birman EG, Cury AE (2004) Oropharyngeal candidiasis in HIV-infected patients under treatment with protease inhibitors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98:301\u2013310. doi: 10.1016\/j.tripleo.2004.05.017","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"2240_CR74","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.prrv.2009.09.001","volume":"10","author":"AC Pasqualotto","year":"2009","unstructured":"Pasqualotto AC (2009) Candida and the paediatric lung. Paediatr Respir Rev 10:186\u2013191. doi: 10.1016\/j.prrv.2009.09.001","journal-title":"Paediatr Respir Rev"},{"key":"2240_CR75","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.trsl.2012.02.005","volume":"160","author":"JM Beck","year":"2012","unstructured":"Beck JM, Young VB, Huffnagle GB (2012) The microbiome of the lung. Transl Res 160:258\u2013266. doi: 10.1016\/j.trsl.2012.02.005","journal-title":"Transl Res"},{"issue":"3","key":"2240_CR76","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s12281-012-0091-0","volume":"6","author":"MA Pfaller","year":"2012","unstructured":"Pfaller MA, Castanheira M, Lockhart SR, Jones RN (2012) Candida glabrata: multidrug resistance and increased virulence in a major opportunistic fungal pathogen. Curr Fungal Infect Rep 6(3):154\u2013164. doi: 10.1007\/s12281-012-0091-0","journal-title":"Curr Fungal Infect Rep"},{"key":"2240_CR77","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.diagmicrobio.2010.01.002","volume":"67","author":"MA Pfaller","year":"2010","unstructured":"Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Barton R, Bijie H et al (2010) Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program. Diagn Microbiol Infect Dis 67:162\u2013171. doi: 10.1016\/j.diagmicrobio.2010.01.002","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-014-2240-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-014-2240-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-014-2240-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T21:06:12Z","timestamp":1565989572000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-014-2240-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,16]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["2240"],"URL":"https:\/\/doi.org\/10.1007\/s10096-014-2240-6","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,16]]}}}